CoChat

Value of Neuropsychological Tests, Neuroimaging, and Biomarkers for Diagnosing Alzheimer's Disease in Younger and Older Age Cohorts

Schmand, Ben, Eikelenboom, Piet, van Gool, Willem A., the Alzheimer's Disease Neuroimaging Initiative · 2011 · Journal of the American Geriatrics Society
Cited by 70

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

OBJECTIVES: To examine the influence of age on the value of four techniques for diagnosing Alzheimer's disease (AD). DESIGN: Observational cohort study. SETTING: Alzheimer's Disease Neuroimaging Initiative. PARTICIPANTS: Individuals with mild cognitive impairment (MCI; n=179), individuals with AD (n=91), and normal controls (n=105). MEASUREMENTS: Neuropsychological tests, structural magnetic resonance imaging (MRI), amyloid‐beta and tau in cerebrospinal fluid (CSF), and [18F]fluorodeoxyglucose positron emission tomography (FDG‐PET) for the diagnosis of MCI or AD. MCI was defined according to subjective memory complaints corroborated by an informant and an abnormal score on the delayed paragraph recall subtest of the Wechsler Memory Scale–Revised, a Mini‐Mental State Examination score greater than 23, and a Clinical Dementia Rating score of 0.5. Participants with AD satisfied National Institute of Neurological and Communicative Diseases and Stroke/Alzheimer's Disease and Related Disorders Association criteria of probable AD. RESULTS: Neuropsychological tests and MRI were the most informative techniques, with 84% and 82% correct classifications, respectively, and areas under the receiver operating characteristic curve (AUCs) of 0.93 (90% confidence interval (CI)=0.91–0.95) and 0.88 (90% CI=0.85–0.91). FDG‐PET and CSF assessments had 76% and 73% correct classifications, respectively, (AUC=0.77, 90% CI=0.71–0.83; AUC=0.77, 90% CI=0.73–0.82). These figures increased slightly when the techniques were combined. All analyses were repeated for the younger (<75) and older (≥75) halves of the sample. FDG‐PET and CSF assessment were substantially less informative in the older cohort, and they did not add diagnostic information when all techniques were combined. CONCLUSIONS: Structural MRI and neuropsychological assessment are diagnostic methods of first choice if AD is suspected. CSF and FDG‐PET add little to these diagnostic techniques, especially in older adults.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1532-5415.2011.03539.x

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 70

Metadata

Authors
Schmand, B., Eikelenboom, P., van Gool, W. A., & Initiative, T. A. D. N.
Venue
Journal of the American Geriatrics Society
Publisher
Wiley
Published
2011-08-24
Volume
59
Issue
9
Pages
1705-1710
ISSN
  • 0002-8614 (ISSN-L)
  • 1532-5415
OpenAlex
W1542623975
Cited by
70
References
7
FWCI
5.91
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Value of Neuropsychological Tests, Neuroimaging, and Biomarkers for Diagnosing Alzheimer's Disease in Younger and Older Age Cohorts. https://app.cochat.ai/papers/10.1111/j.1532-5415.2011.03539.x
The paper
Schmand, B., Eikelenboom, P., van Gool, W. A., & Initiative, T. A. D. N. (2011). Value of Neuropsychological Tests, Neuroimaging, and Biomarkers for Diagnosing Alzheimer's Disease in Younger and Older Age Cohorts. Journal of the American Geriatrics Society. https://doi.org/10.1111/j.1532-5415.2011.03539.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.